Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Mal-PEG2-VCP-Eribulin | 2130869-18-8 | 99.8% | 1374.57 | 5 MG
SDP

Supplier:  Medchemexpress LLC 5MGHY128870

Encompass_Preferred

Mal-PEG2-VCP-Eribulin is a drug-linker conjugate for ADCs, combining an ADCs linker (Mal-PEG2-VCP) with Eribulin. Eribulin is a mechanistically unique microtubule inhibitor that inhibits the proliferation of cancer cells by binding to microtubule proteins and microtubules. This Eribulin-based agent is designed for antibody conjugates and is intended for research use only.

  • Drug-linker conjugate for ADCs
  • Contains ADCs linker (Mal-PEG2-VCP)
  • Incorporates Eribulin, a microtubule inhibitor
  • Inhibits cancer cell proliferation
  • Suitable for antibody conjugates
  • For research use only

Catalog No. 50-003-64629


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.